Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micropoint Biotechnologies
Shenzhen, Guangdong, Chinamicropointbio.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Micropoint Biotechnologies has developed and commercialized a range of rapid point-of-care diagnostic products using microfluidic lab-on-a-chip technology. Their qLabs system enables monitoring for warfarin anti-coagulated therapy and other cardiovascular diagnostics. The company’s products are distributed globally through over 100 partners.
- Therapeutic areas
- CardiovascularInfectious Diseases
- Modalities
- Device
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Over 100 distribution partners worldwide
Beyond the preview
Go deeper on Micropoint Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Micropoint Biotechnologies.